Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age.
Background: The Oncotype DX 21-gene Recurrence Score is a genomic-based algorithm that guides adjuvant chemotherapy treatment decisions for women with early-stage, oestrogen receptor (ER)-positive breast cancer. However, there are age-related differences in chemotherapy benefit for women with interm...
| Publicado en: | Breast Cancer Research Vol. 22; no. 1 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | research Journal Article |
| Publicado: |
BioMed Central
8/18/2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |